Robin Shane Readnour - Net Worth and Insider Trading
Robin Shane Readnour Net Worth
The estimated net worth of Robin Shane Readnour is at least $9 Million dollars as of 2025-01-09. Robin Shane Readnour is the Director of Elevance Health Inc and owns about 487,592 shares of Elevance Health Inc (ANTX) stock worth over $8 Million. Robin Shane Readnour is also the Director of AN2 Therapeutics Inc and owns about 1,234,861 shares of AN2 Therapeutics Inc (ANTX) stock worth over $2 Million. Details can be seen in Robin Shane Readnour's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robin Shane Readnour has not made any transactions after 2024-12-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Robin Shane Readnour
Robin Shane Readnour Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robin Shane Readnour owns 1 companies in total, including AN2 Therapeutics Inc (ANTX) .
Click here to see the complete history of Robin Shane Readnour’s form 4 insider trades.
Insider Ownership Summary of Robin Shane Readnour
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ANTX | AN2 Therapeutics Inc | 2024-12-10 | director |
Robin Shane Readnour Latest Holdings Summary
Robin Shane Readnour currently owns a total of 2 stocks. Among these stocks, Robin Shane Readnour owns 487,592 shares of Elevance Health Inc (ANTX) as of March 29, 2022, with a value of $8 Million and a weighting of 82.79%. Robin Shane Readnour also owns 1,234,861 shares of AN2 Therapeutics Inc (ANTX) as of December 10, 2024, with a value of $2 Million and a weighting of 17.21%.
Latest Holdings of Robin Shane Readnour
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ANTX | Elevance Health Inc | 2022-03-29 | 487,592 | 15.84 | 7,723,457 |
| ANTX | AN2 Therapeutics Inc | 2024-12-10 | 1,234,861 | 1.30 | 1,605,319 |
Holding Weightings of Robin Shane Readnour
Robin Shane Readnour Form 4 Trading Tracker
According to the SEC Form 4 filings, Robin Shane Readnour has made a total of 1 transactions in Elevance Health Inc (ANTX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Elevance Health Inc is the acquisition of 153,334 shares on March 29, 2022, which cost Robin Shane Readnour around $2 Million.
According to the SEC Form 4 filings, Robin Shane Readnour has made a total of 5 transactions in AN2 Therapeutics Inc (ANTX) over the past 5 years, including 3 buys and 2 sells. The most-recent trade in AN2 Therapeutics Inc is the acquisition of 60,000 shares on December 10, 2024, which cost Robin Shane Readnour around $87,000.
Insider Trading History of Robin Shane Readnour
- 1
Robin Shane Readnour Trading Performance
GuruFocus tracks the stock performance after each of Robin Shane Readnour's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robin Shane Readnour is %. GuruFocus also compares Robin Shane Readnour's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robin Shane Readnour within 3 months outperforms times out of transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Robin Shane Readnour's insider trading performs compared to the benchmark.
Performance of Robin Shane Readnour
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -2.19 |  | | | | |
| Relative Return to S&P 500(%) | -1.27 | | | | | |
Robin Shane Readnour Ownership Network
Robin Shane Readnour Owned Company Details
What does AN2 Therapeutics Inc do?
Who are the key executives at AN2 Therapeutics Inc?
Robin Shane Readnour is the director of AN2 Therapeutics Inc. Other key executives at AN2 Therapeutics Inc include Chief Development Officer Sanjay Chanda , Chief Financial Officer Lucy Day , and See Remarks Joshua M Eizen .
AN2 Therapeutics Inc (ANTX) Insider Trades Summary
Over the past 18 months, Robin Shane Readnour made 5 insider transaction in AN2 Therapeutics Inc (ANTX) with a net purchase of 329,906. Other recent insider transactions involving AN2 Therapeutics Inc (ANTX) include a net sale of 223,880 shares made by Kabeer Aziz , a net sale of 223,880 shares made by Adjuvant Global Health Technology Fund De, L.p. , and a net sale of 73,000 shares made by Joseph S Zakrzewski .
In summary, during the past 3 months, insiders sold 17,606 shares of AN2 Therapeutics Inc (ANTX) in total and bought 412,000 shares, with a net purchase of 394,394 shares. During the past 18 months, 4,108,331 shares of AN2 Therapeutics Inc (ANTX) were sold and 3,689,778 shares were bought by its insiders, resulting in a net sale of 418,553 shares.
AN2 Therapeutics Inc (ANTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
AN2 Therapeutics Inc Insider Transactions
Robin Shane Readnour Mailing Address
Above is the net worth, insider trading, and ownership report for Robin Shane Readnour. You might contact Robin Shane Readnour via mailing address: 3835 Cleghorn Avenue, Suite 300, Nashville Tn 37215.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
